Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Convertible Debt (2019 - 2024)

Scynexis' (SCYX) quarterly Convertible Debt came in at $13.7 million in Q4 2024, up 12.58% on a YoY basis from $12.2 million in Q1 2024, and up 12.58% quarter-over-quarter from $12.2 million in Q4 2023.

Analysis

Scynexis (SCYX) Convertible Debt (2019 - 2024) Analysis & Trends

Scynexis (SCYX) has reported Convertible Debt for 6 consecutive years, with $13.7 million the latest figure, recorded in Q4 2024.

  • For the quarter ending Q4 2024, Convertible Debt rose 12.58% year-over-year to $13.7 million; the trailing twelve-month figure through Dec 2024 stood at $13.7 million (up 12.58% YoY), and the FY2024 full-year result was $13.7 million, up 12.58% from the prior year.
  • Convertible Debt improved to $13.7 million in Q4 2024 per SCYX's latest filing, from $12.2 million in the prior quarter.
  • Across five years, Convertible Debt topped out at $18.3 million in Q2 2020 and bottomed at $10.8 million in Q3 2021.
  • Historically, Convertible Debt has averaged $12.4 million across 5 years, with a median of $11.6 million in 2023.
  • The widest YoY moves for Convertible Debt: up 43.34% in 2020, down 39.33% in 2020.
  • Over 5 years, Convertible Debt stood at $16.5 million in 2020, then retreated by 29.72% to $11.6 million in 2021, then dropped by 5.22% to $11.0 million in 2022, then grew by 10.53% to $12.2 million in 2023, then gained by 12.58% to $13.7 million in 2024.
  • According to Business Quant data, Convertible Debt over the past three periods registered $13.7 million, $12.2 million, and $11.8 million for Q4 2024, Q4 2023, and Q3 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Scynexis 58.41 Mn -56.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 13.69 Mn
Dec 31, 2023 12.16 Mn
Sep 30, 2023 11.81 Mn
Jun 30, 2023 11.63 Mn
Mar 31, 2023 11.41 Mn
Dec 31, 2022 11.00 Mn
Sep 30, 2022 11.03 Mn
Jun 30, 2022 10.82 Mn
Mar 31, 2022 10.82 Mn
Dec 31, 2021 11.61 Mn
Sep 30, 2021 10.81 Mn
Jun 30, 2021 12.00 Mn
Mar 31, 2021 12.23 Mn
Dec 31, 2020 16.52 Mn
Sep 30, 2020 13.28 Mn
Jun 30, 2020 18.25 Mn
Mar 31, 2020 11.10 Mn
Dec 31, 2019 11.52 Mn
Sep 30, 2019 12.57 Mn
Jun 30, 2019 14.59 Mn